Prostatic growth factor
US7282351B2 · kind B2 · utility
25Cited by
9References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2002 |
| Grant date | Oct 16, 2007 |
| Priority date | — |
| Expiry date | Oct 24, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/854
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to human PGF polypeptides and DNA (RNA) encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques, and antibodies and antagonist/inhibitors against such polypeptides. Also provided are methods of using such polypeptides therapeutically for treating prostate cancer, to promote tissue regeneration and to facilitate wound healing. Also provided is a diagnostic assay to detect prostate cancer and benign prostatic hyperplasia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.